MAP17 is a nonglycosylated membrane-associated protein that has been shown to be overexpressed in human carcinomas, suggesting a possible role of this protein in tumorigenesis. However, very little is known about the molecular mechanism mediating the possible tumor promoting properties of MAP17. To analyze the effect of MAP17 on cell survival we used Rat1 fibroblasts model where Myc overexpression promotes apoptosis in low serum conditions. In the present work we report that overexpression of MAP17 protects Rat1a fibroblasts from Myc-induced apoptosis through ROS-mediated activation of the PI3K/AKT signaling pathway. MAP17-mediated survival was associated with absence of Bax translocation to the mitochondria and reduced caspase3 activation. We show that a fraction of PTEN undergoes oxidation in MAP17-overexpressing cells. Furthermore, activation of AKT by MAP17 as measured by Thr308 phosphorylation was independent of PI3K activity. Importantly, modulation of ROS by antioxidant treatment prevented activation of AKT, restoring the level of apoptosis in serum starved Rat1/c-Myc fibroblasts.
INTRODUCTION
Although multiple oncogenes that activate signaling pathways directly involved in cell survival or proliferation have been discovered in the last decades, many other genes that provide an advantage to the tumoral cells making them insensitive to physiological signals or altering their normal physiology are still to be found. Functional genetic screens using retroviral delivery of high complexity cDNA libraries constitute a valuable tool to discover new genes involved in the appropriate phenotypic characteristic of the tumoral cell .
We designed a genome-wide retroviral cDNA screen to search for genes that confer to cancer cells the ability to evade the normal physiological responses directed to maintain tissue homeostasis [1] . We identified MAP17, a small non-glycosylated membraneassociated protein of 17 KDa that locates to the plasma membrane and the Golgi apparatus [2] [1] . The protein has two transmembrane domains and a PDZ-binding domain in the carboxy-terminus [3] . MAP17 acts as an atypical anchoring site for PDZK1 and interacts with the NaPi-IIa/PDZK1 protein complex in renal proximal tubular cells [4] . The physiological role of MAP17 in proximal tubules is not known but it stimulates specific Na-dependent transport of mannose and glucose in Xenopus oocytes [2] and several human cell lines [1] . Ectopic expression of MAP17 in tumor cells prevents TNF-induced G1 arrest by impairing p21waf1 induction. The inhibition of TNF is specific since MAP17 does not alter the response to other cytokines such as IFNγ [1] . MAP17 is overexpressed in a great variety of human carcinomas [5] [6] and, at least in prostatic and ovarian carcinomas, the overexpression of the protein strongly correlates with tumoral progression. Despite the common overexpression of MAP17 among carcinomas of different origins, there are no reports suggesting a possible role of MAP17 in tumorigenesis that could explain this distribution.
In the present work we show that ectopic overexpression of MAP17 can rescue Rat1 fibroblasts from c-myc-induced apoptosis. We provide evidence that MAP17 induces survival signaling through ROS-mediated activation of the PI3K/AKT pathway, and this activation is essential promoting MAP17 survival in the absence of serum.
MATERIALS AND METHODS
Cell culture conditions. Rat1 fibroblasts and LinXE ecotropic retrovirus producer cells [7] were grown in Dulbecco's modified Eagle's medium with glutamax supplemented with 10% fetal bovine serum (FBS), penicillin, streptomycin and fungizone. Retroviral constructs were introduced into packaging cells by standard calcium phosphate transfection. Retroviral-mediated gene transfer was performed as previously described in [7] . Briefly, packaging cells were transfected by calcium phosphate. After 48 h, the virus-containing medium was filtered, added 8 µg/ml polybrene (Sigma) and fresh medium. Target cells were incubated overnight with the appropriate viral supernatant.
The infected cell population was purified using the appropriate culture selection.
MAP17 full cDNA was cloned in pBabepuro and clones generated by Retroviralmediated gene transfer. Numerous clones were selected and tested. All behave similarly.
In this work 3 representative clones are shown.
Treatments. Both N-acetyl-cysteine (NAC) and reduced glutathione (GSH) were purchased from Sigma and cells were incubated with 10 mM of either NAC or GSH as indicated. Monoclonal anti-MAP17 antibody was generated by the Monoclonal Antibody Unit of the CNIO. We used a GST-MAP17 fusion protein purified from E.coli as immunogen.
Cell death measurement.
Different antibodies were tested and validated by antigenic competition.
Immunostaining and confocal analysis. Cells were seeded at a density of 10 were rinsed in phosphate-buffered saline and fixed in 0.5% glutaraldehyde (Sigma).
Fixed fibroblasts were stained for 30 min in 0.1% crystal violet solution.
RESULTS

MAP17 inhibits myc-induced apoptosis in low serum conditions.
To investigate the contribution of MAP17 to survival signaling we took advantage of the experimental system described by Evan and coworkers [8] . The human c-Myc gene constitutively driven by an LTR promoter was transduced into Rat-1 fibroblasts and cells stably expressing c-myc (RatMyc) selected [9] . RatMyc fibroblasts were then infected with a retrovirus carrying the full MAP17 cDNA. We selected several clones and characterized the MAP17 mRNA expression by RT-PCR. All the clones analyzed expressed considerable amounts of MAP17 mRNA in contrast with the Rat1Myc cells carrying an empty vector (RatMyc-P) which do not express endogenous MAP17. To determine the protein level we generated mouse monoclonal antibodies using recombinant MAP17 produced in E. coli as immunogen [6] . We determined the ectopic To further understand the mechanism by which MAP17 mediates cell survival in serum deprived RatMyc cells, we examined whether MAP17 was able to reduce caspase activity. We prepared cell lysates from control RatMyc parental cells and from representative MAP17 expressing clones before and after serum deprivation. By using the fluorogenic substrate, Ac-DEVD-MCA we measured the caspase 3-like protease activity. Ac-DEVD-MCA processing caspase 3-like activity was significantly induced after 12 h of serum starvation in parental cells. The expression of MAP17 reduced caspase 3-like activity between 40% and 60% in serum starving conditions (Fig. 2B) .
It has been shown that the apoptotic process initiated by serum withdrawal in Myc expressing cells rely on the ability of Bax to translocate to mitochondria [10] . Therefore we monitored the intracellular localization of Bax protein. Cells were subjected to serum withdrawal for 24 hrs and then stained for mitochondria and Bax with fluorescent antibodies. Serum-starved Rat1Myc parental cells showed an increase in Bax immunofluorescence localized in the mitochondria (Fig 2C) . In contrast, the MAP17 expressing clones analyzed showed only a mild increase in Bax and no translocation to the mitochondria ( Figure 2C ). Almost 50% of serum depleted parental cells showed Bax traslocation after 24 hrs, while that phenotype was observed in less than 10% of cells in MAP17 clones ( Figure 2D ).
Taken together, these data indicate that MAP17 drastically reduces serum deprivationinduced apoptosis in Rat1Myc cells.
MAP17 activates PI3K pathway.
Activation of PI3K pathway has been shown to inhibit Myc-induced apoptosis in the absence of serum. Since AKT is one of the major downstream effectors of the PI3K survival signaling pathway, we analyzed whether MAP17 apoptotic protection in low serum conditions was due to the activation of AKT. We monitored AKT activation analyzing its phosphorylation at Thr308 and Ser473 with specific antibodies. Figure 3 shows that ectopic expression of MAP17 did not alter AKT phosphorylation at Ser473 in the presence of serum. While in parental cells AKT activation, measured as Ser473 phosphorylation, was reduced more than 50% after serum deprivation, the presence of To study the potential role of MAP17-induced ROS in cell survival we first investigated whether AKT phosphorylation in MAP17-expressing clones was dependent on the production of ROS. Parental RatMyc cells and the MAP17-expressing clones were cultured in the presence of the antioxidants GSH or N-acetylcysteine (NAC). The activity of the PI3K/AKT pathway was assessed by western blot using a specific antibody against AKT phosphorylation on Ser473. We observed that in MAP17-expressing cells the treatment with antioxidants reduced AKT phosphorylation in the absence of serum, confirming that the protection observed in such conditions in MAP17 expressing clones was due to the induction of ROS ( Figure 4C ). However, no reduction in AKT phosphorylation was observed in 10% serum, indicating that in such conditions ROS are not necessary to maintain AKT activation.
To investigate the link between the production of ROS induced by MAP17 and the protection from apoptosis, we measured the survival of MAP17 expressing clones, serum starved, in the presence of antioxidants. Addition of 10 mM NAC to the serumfree medium clearly reduced the survival of MAP17 expressing clones while NAC does not affect growth in 10% growth (Fig 5) . These results suggests that the generation of ROS acting as a mediator of MAP17-induced survival through PI3K/AKT signaling.
Since ROS can oxidize PTEN and inactivate its phosphatase activity, we analyzed PTEN oxidation in MAP17-expressing Rat1Myc cells ( Figure 6A ). Total protein was extracted from exponentially-growing cells and PTEN analyzed by PAGE-Western Blot in non-oxidant conditions (see Materials and Methods). Oxidized PTEN can be distinguished by its different mobility (Fig 6A) . MAP17 increased 6-10 folds the levels of oxidized PTEN in serum starved cells (Fig 6A and B) . Also, an increased level of oxidized PTEN was found in cells growing in the presence of serum (Data not shown).
This result suggests that ROS might oxidize and inactivate PTEN maintaining, therefore, the PI3K pathway activated in the absence of serum. Additionally, ROS has been shown to oxidize and inactivate several phosphatases containing cysteine residues in its active centre. In order to investigate additional mechanisms that might support
MAP17-mediated survival we tested the effect of PI3K inhibition on AKT activity in MAP17 expressing cells. Surprisingly, in contrast to phosphorylation at Ser473, which was significantly reduced in the presence of the PI3K inhibitor LY294002, the phosphorylation at Thr308 seemed to be independent of the upstream PI3K activity ( Figure 6C ). This result suggests the existence of a PTEN-independent target of ROS impacting specifically on AKT phosphorylation at Thr308.
In order to further analyze the implication of Akt activation in MAP17 mediated protection from c-Myc-induced apoptosis, we performed clonogenic survival assays in the presence of an Akt derivate that carries a K179M point mutation resulting in a loss of kinase activity [14] . 
DISCUSSION
The present study provides insights into the ROS mediated activation of an antiapoptotic signaling pathway by MAP17. We evaluated the effects of ectopic expression of MAP17 in Rat1 fibroblasts that stably co-express c-MYC.
Sensitization to apoptotic stimuli is an intrinsic c-Myc activity which is suppressed by the survival factors present in fetal bovine serum under normal cell culture conditions.
Thus, c-Myc induces cell death upon attenuation of the counteracting survival signalling through serum deprivation [8] . We have shown previously that the degree of cell death in Rat-1/Myc cells expressing myristoylated forms of p110α, p110β, p110δ or p110γ
was dramatically reduced even in the complete absence of serum [9] . Hence, introducing MAP17 in this well established apoptosis model appears to be a suitable strategy to test its efficiency promoting survival signalling. Interestingly, the degree of protection from c-Myc-induced apoptosis conferred by ectopic expression of MAP17 or activated forms of PI3K were very similar. In order to test the hypothesis that PI3K and MAP17-triggered protection is mediated by a common mechanism we assessed the impact of ectopic MAP17 expression on the activity of AKT, the greater downstream effector of PI3K signaling. Activation of AKT involves sequential phosphorylation at two key residues located at the catalytic site (T loop) and the C-terminal hydrophobic motif. PDK1 phosphorylates AKT at Thr308 of its T loop, which is essential for AKT catalytic activity. Recent studies strongly suggest that rapamycin insensitive TOR complex 2 (TORC2) is responsible for Ser473 phosphorylation at the hydrophobic motif. Interestingly, in the presence of serum, ectopic expression of MAP17 triggers a dramatic increase of Thr308 phosphorylation, whereas Ser473 remains unaffected. Dephosphorylation of AKT has been associated with PP2A phosphatase activity. A recent study reports the identification of a specific Ser473 phosphatase [15] . We hypothesize that MAP17 mediates the inhibition of a Thr308 specific phosphatase activity. Further experiments are required to identify the putative phosphatase that specifically dephosphorylates Thr308 and shed light on the mechanism by which MAP17 might blocks its activity.
On the other hand, ROS can directly modify signaling proteins through nitrosylation, carbonylation, glutathionylation and formation of disulphide bonds [18] . The crystal structure of inactive AKT2 reveals a possible redox sensitive intramolecular disulfide bond in its activating loop [19] , between Lys297 and Cys301 [20] . We have found that 
